4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0000950170-24-139052
CHIEF ACCOUNTING OFFICER sold 1,235 shares at $2.02 ($2,495)
- CHIEF ACCOUNTING OFFICER acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-12-18 | Option exercise 10b5-1 | +5,000 | 12,564 | D: show line 1 in the form | ||
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-12-19 | Sale 10b5-1 | −1,235 | $2.02 | $2,495 | 11,329 | D: show line 2 in the form |
| Open-market sales · 1,235 sh · avg $2.02 · $2,495 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-12-18 | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 25,000 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…